The Division of Hematology, Oncology and Cell Therapy in the Department of Medicine at Rush University Medical Center is recruiting a Senior Medical Oncologist with interest in lung oncology at the associate or professor level. The successful candidate will be board certified in medical oncology and have demonstrated leadership in the field of Thoracic Oncology on a national level. The successful candidate will have a Co-Directorship in a well-developed multidisciplinary program that includes at least 3 full-time dedicated thoracic oncologists, 5 full-time thoracic surgeons and a full-time radiation oncologist all dedicated to lung cancer and other chest malignancies. The predominant criteria include: a major commitment to research and scholarly activity that advances the field of medicine, teaching, excellence in clinical care, and institutional service appropriate to the programmatic need the individual is expected to fulfill.
Rush University Medical Center is an Equal Opportunity/Affirmative action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability or Protected Veteran status.
job, healthcare, licensure, medical, clinical, wellness, career, employment, opening, staff, benefits, health care, clinic, Chicago
In U.S. News & World Report’s 2019-2020 “America’s Best Hospitals” issue, Rush ranked among the top 50 hospitals in five specialties — with two in the top ten — and is one of the two top-ranked hospitals in Illinois overall. Rush has been a Magnet® nursing organization for more than 10 years.
Rush is united by diversity, inclusion and a commitment to health equity. Rush is also a perennial “Leader in LGBT Healthcare Equality.”
Quality of life
Chicago offers an excellent selection of homes in downtown, suburban and rural locations, as well as public and private schools and colleges. Local museums, entertainment, culture and the arts are world-class. Celebrated restaurants, craft breweries and local distilleries abound.
Research at Rush
Rush is currently involved in more than 1,600 research studies, many NIH-funded. Rush’s long tradition of discovery dates back to determining the causes of scarlet fever, heart attacks and sickle cell anemia. Today we’re also leaders in neurosciences, cancer, immunology, infection, regenerative medicine and more. Join us in spearheading life-changing research at the national level.